Snowden Capital Advisors’s National Healthcare NHC Stock Holding History

Snowden Capital Advisors’s Portfolio NHC Stock Details NHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-14	Closed	–	–	1691
2021 Q4	$0	Buy	+14	New	+$969	﹤0.01%	2100

Other funds holding NHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Snowden Capital Advisors's NHC Position: Q1 2022 in Review

Snowden Capital Advisors sold out of National Healthcare (NHC) in Q1 2022, closing a stake of 14 shares.

Snowden Capital Advisors first reported a position in NHC in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 122 funds tracked by Wall St. Rank hold NHC as of Q1 2022.

Snowden Capital Advisors reported no remaining National Healthcare position as of Q1 2022 after selling out during the quarter.
Snowden Capital Advisors sold 14 National Healthcare shares in Q1 2022.
Snowden Capital Advisors first reported a position in National Healthcare in Q4 2021 and held it in 1 quarter.
Snowden Capital Advisors's National Healthcare position peaked at $0 in Q4 2021.
122 funds tracked by Wall St. Rank held National Healthcare as of Q1 2022.

Based on Snowden Capital Advisors's 13F filing for Q1 2022, filed 16 May 2022.